Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients.

Hazem I Assi Ibrahim A AlamehJessica KhouryNour Abdul HalimFadi El KarakFadi FarhatJuliett BerroEman SbaityMaya CharafeddineArafat TfayliZiad SalemNagi El Saghir

Published in: Journal of oncology (2020)

Our study demonstrates the importance of genomics testing, as it assisted physicians in avoiding unnecessary adjuvant chemotherapy in 25.33% of patients, thus reducing side effects of chemotherapy and the financial burden on patients.

Keyphrases

early stage
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
primary care
prognostic factors
peritoneal dialysis
radiation therapy
patient reported outcomes
lymph node
genome wide
dna methylation
single cell